首页 > 最新文献

Journal of multimorbidity and comorbidity最新文献

英文 中文
Developing SysteMatic: Prevention, precision and equity by design for people living with multiple long-term conditions. 开发 SysteMatic:为患有多种长期疾病的人设计预防、精准和公平的方案。
Pub Date : 2024-09-30 eCollection Date: 2024-01-01 DOI: 10.1177/26335565241272682
Frances S Mair, Farnaz Nickpour, Barbara Nicholl, Sara MacDonald, Dan W Joyce, Jonathan Cooper, Nic Dickson, Isobel Leason, Qammer H Abbasi, Izzettin F Akin, Fani Deligianni, Elizabeth Camacho, Jennifer Downing, Hilary Garrett, Martina Johnston Gray, David J Lowe, Muhammad A Imran, Sandosh Padmanabhan, Colin McCowan, P John Clarkson, Lauren E Walker, Iain Buchan

Background: The number of individuals living with multiple (≥2) long term conditions (MLTCs) is a growing global challenge. People with MLTCs experience reduced life expectancy, complex healthcare needs, higher healthcare utilisation, increased burden of treatment, poorer quality of life and higher mortality. Evolving technologies including artificial intelligence (AI) could address some of these challenges by enabling more preventive and better integrated care, however, they may also exacerbate inequities.

Objective: We aim to deliver an equity focused, action-ready plan for transforming MLTC prevention and care, co-designed by people with lived experience of MLTCs and delivered through an Innovation Hub: SysteMatic.

Design: Our Hub is being co-designed by people with lived experience of MLTCs, practitioners, academics and industry partners in Liverpool and Glasgow, UK. This work builds on research into mental-physical health interdependence across the life-course, and on mobilisation of large-scale quantitative data and technology validation in health and care systems serving deprived populations in Glasgow and Liverpool. We work with 3 population segments: 1) Children & Families: facing psychosocial and environmental challenges with lifetime impacts; 2). Working Life: people with poorly integrated mental, physical and social care; and 3) Pre-Frailty: older people with MLTCs. We aim to understand their experiences and in parallel look at routinely collected health data on people with MLTCs to help us identify targets for intervention. We are co-identifying opportunities for systems transformation with our patient partners, healthcare professionals and through discussion with companies and public-sector organisations. We are co-defining 3/5/7-year MLTC innovation/transition targets and sustainable learning approaches.

Discussion: SysteMatic will deliver an actionable MLTC Innovation Hub strategic plan, with investment from the UK National Health Service, civic health and care partners, universities, and industry, enabling feedback of well-translated, patient and public prioritised problems into the engineering, physical, health and social sciences to underpin future equitable innovation delivery.

背景:患有多种(≥2 种)长期疾病(MLTCs)的人数是一项日益严峻的全球性挑战。多重长期病症患者的预期寿命缩短、医疗保健需求复杂、医疗保健使用率高、治疗负担加重、生活质量较差、死亡率较高。包括人工智能(AI)在内的不断发展的技术可以通过提供更具预防性和更好的综合护理来应对其中的一些挑战,但它们也可能加剧不平等:我们的目标是提供一个以公平为重点、可付诸行动的计划,以改变多发性骨髓瘤的预防和护理,该计划由多发性骨髓瘤患者共同设计,并通过创新中心实施:设计:我们的枢纽由英国利物浦和格拉斯哥的多发性精神障碍患者、从业人员、学者和行业合作伙伴共同设计。这项工作的基础是对整个生命过程中精神与身体健康相互依存关系的研究,以及在为格拉斯哥和利物浦贫困人口提供服务的医疗和护理系统中调动大规模定量数据和技术验证。我们的工作涉及三个人群1) 儿童和家庭:面临影响一生的社会心理和环境挑战;2).2) 工作生活:精神、身体和社会护理整合不佳的人群;以及 3) 虚弱前期:患有多发性硬化症的老年人。我们的目标是了解他们的经历,并同时研究常规收集的有关多器官功能障碍患者的健康数据,以帮助我们确定干预目标。我们正在与患者伙伴、医疗保健专业人员共同确定系统转型的机会,并与公司和公共部门组织进行讨论。我们正在共同确定 3/5/7 年的多发性骨髓瘤创新/过渡目标以及可持续的学习方法:SysteMatic 将在英国国家医疗服务机构、民间医疗和护理合作伙伴、大学和行业的投资下,实施一项可操作的 MLTC 创新中心战略计划,将患者和公众优先考虑的问题反馈到工程、物理、健康和社会科学中,以支持未来公平的创新交付。
{"title":"Developing SysteMatic: Prevention, precision and equity by design for people living with multiple long-term conditions.","authors":"Frances S Mair, Farnaz Nickpour, Barbara Nicholl, Sara MacDonald, Dan W Joyce, Jonathan Cooper, Nic Dickson, Isobel Leason, Qammer H Abbasi, Izzettin F Akin, Fani Deligianni, Elizabeth Camacho, Jennifer Downing, Hilary Garrett, Martina Johnston Gray, David J Lowe, Muhammad A Imran, Sandosh Padmanabhan, Colin McCowan, P John Clarkson, Lauren E Walker, Iain Buchan","doi":"10.1177/26335565241272682","DOIUrl":"10.1177/26335565241272682","url":null,"abstract":"<p><strong>Background: </strong>The number of individuals living with multiple (≥2) long term conditions (MLTCs) is a growing global challenge. People with MLTCs experience reduced life expectancy, complex healthcare needs, higher healthcare utilisation, increased burden of treatment, poorer quality of life and higher mortality. Evolving technologies including artificial intelligence (AI) could address some of these challenges by enabling more preventive and better integrated care, however, they may also exacerbate inequities.</p><p><strong>Objective: </strong>We aim to deliver an equity focused, action-ready plan for transforming MLTC prevention and care, co-designed by people with lived experience of MLTCs and delivered through an Innovation Hub: SysteMatic.</p><p><strong>Design: </strong>Our Hub is being co-designed by people with lived experience of MLTCs, practitioners, academics and industry partners in Liverpool and Glasgow, UK. This work builds on research into mental-physical health interdependence across the life-course, and on mobilisation of large-scale quantitative data and technology validation in health and care systems serving deprived populations in Glasgow and Liverpool. We work with 3 population segments: 1) Children & Families: facing psychosocial and environmental challenges with lifetime impacts; 2). Working Life: people with poorly integrated mental, physical and social care; and 3) Pre-Frailty: older people with MLTCs. We aim to understand their experiences and in parallel look at routinely collected health data on people with MLTCs to help us identify targets for intervention. We are co-identifying opportunities for systems transformation with our patient partners, healthcare professionals and through discussion with companies and public-sector organisations. We are co-defining 3/5/7-year MLTC innovation/transition targets and sustainable learning approaches<b>.</b></p><p><strong>Discussion: </strong>SysteMatic will deliver an actionable MLTC Innovation Hub strategic plan, with investment from the UK National Health Service, civic health and care partners, universities, and industry, enabling feedback of well-translated, patient and public prioritised problems into the engineering, physical, health and social sciences to underpin future equitable innovation delivery.</p>","PeriodicalId":73843,"journal":{"name":"Journal of multimorbidity and comorbidity","volume":"14 ","pages":"26335565241272682"},"PeriodicalIF":0.0,"publicationDate":"2024-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11447698/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142373728","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Corrigendum to "Epidemiology and impact of chronic disease multimorbidity in India: a systematic review and meta-analysis". 印度慢性病多发病的流行病学及其影响:系统回顾和荟萃分析 "的更正。
Pub Date : 2024-09-16 eCollection Date: 2024-01-01 DOI: 10.1177/26335565241283936

[This corrects the article DOI: 10.1177/26335565241258851.].

[此处更正了文章 DOI:10.1177/26335565241258851]。
{"title":"Corrigendum to \"Epidemiology and impact of chronic disease multimorbidity in India: a systematic review and meta-analysis\".","authors":"","doi":"10.1177/26335565241283936","DOIUrl":"https://doi.org/10.1177/26335565241283936","url":null,"abstract":"<p><p>[This corrects the article DOI: 10.1177/26335565241258851.].</p>","PeriodicalId":73843,"journal":{"name":"Journal of multimorbidity and comorbidity","volume":"14 ","pages":"26335565241283936"},"PeriodicalIF":0.0,"publicationDate":"2024-09-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11409281/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142302668","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Epidemiology of multimorbidity in Nepal: A systematic review and meta-analysis. 尼泊尔多病流行病学:系统回顾和荟萃分析。
Pub Date : 2024-09-14 eCollection Date: 2024-01-01 DOI: 10.1177/26335565241284022
Abhinav Sinha, S Shradha Suman, Narayan Subedi, Krushna Chandra Sahoo, Mukesh Poudel, Arohi Chauhan, Banamber Sahoo, Marjan van den Akker, David Weller, Stewart W Mercer, Sanghamitra Pati

Background: Multimorbidity is rising in low-and middle-income countries such as Nepal, yet the research has not gained pace in this field. We aimed to systematically review the existing multimorbidity literature in Nepal and estimate the prevalence and map its risk factors and consequences.

Methods: We reviewed data collated from PubMed, Embase and CINAHL by including original studies that reported prevalence of multimorbidity in Nepal. The quality of included studies was assessed using the Appraisal Tool for Cross-sectional Studies. The summary of the review is presented both qualitatively as well as through meta-analysis to give pooled prevalence. We prospectively registered in PROSPERO (CRD42024499598).

Results: We identified 423 studies out of which seven were included in this review. All studies were conducted in a community setting except one which was hospital based. The prevalence reported across various studies ranged from 13.96% to 70.1%. The pooled prevalence of multimorbidity was observed to be 25.05% (95% CI: 16.99 to 34.09). The number of conditions used to assess multimorbidity ranged from four to nine. The major risk factors identified were increasing age, urban residence, and lower literacy rates.

Conclusion: A wide variance in the prevalence of multimorbidity was observed. Moreover, multimorbidity assessment tool/conditions considered for assessing multimorbidity were heterogeneous.

背景:尼泊尔等中低收入国家的多病症发病率正在上升,但这一领域的研究却没有取得进展。我们的目的是系统回顾尼泊尔现有的多病症文献,估算多病症的发病率,并绘制其风险因素和后果图:我们查阅了从 PubMed、Embase 和 CINAHL 收集的数据,包括报告尼泊尔多病流行情况的原创研究。采用横断面研究评估工具对纳入研究的质量进行了评估。综述既有定性分析,也有通过荟萃分析得出的汇总患病率。我们在 PROSPERO(CRD42024499598)上进行了前瞻性注册:结果:我们确定了 423 项研究,其中 7 项被纳入本综述。所有研究都是在社区环境中进行的,只有一项研究是在医院进行的。各项研究报告的患病率从 13.96% 到 70.1% 不等。据观察,多病共存的患病率为 25.05%(95% CI:16.99 至 34.09)。用于评估多病症的病症数量从 4 种到 9 种不等。发现的主要风险因素是年龄增长、居住在城市和识字率较低:结论:多病症患病率差异很大。此外,多病评估工具/多病评估条件也不尽相同。
{"title":"Epidemiology of multimorbidity in Nepal: A systematic review and meta-analysis.","authors":"Abhinav Sinha, S Shradha Suman, Narayan Subedi, Krushna Chandra Sahoo, Mukesh Poudel, Arohi Chauhan, Banamber Sahoo, Marjan van den Akker, David Weller, Stewart W Mercer, Sanghamitra Pati","doi":"10.1177/26335565241284022","DOIUrl":"https://doi.org/10.1177/26335565241284022","url":null,"abstract":"<p><strong>Background: </strong>Multimorbidity is rising in low-and middle-income countries such as Nepal, yet the research has not gained pace in this field. We aimed to systematically review the existing multimorbidity literature in Nepal and estimate the prevalence and map its risk factors and consequences.</p><p><strong>Methods: </strong>We reviewed data collated from PubMed, Embase and CINAHL by including original studies that reported prevalence of multimorbidity in Nepal. The quality of included studies was assessed using the Appraisal Tool for Cross-sectional Studies. The summary of the review is presented both qualitatively as well as through meta-analysis to give pooled prevalence. We prospectively registered in PROSPERO (CRD42024499598).</p><p><strong>Results: </strong>We identified 423 studies out of which seven were included in this review. All studies were conducted in a community setting except one which was hospital based. The prevalence reported across various studies ranged from 13.96% to 70.1%. The pooled prevalence of multimorbidity was observed to be 25.05% (95% CI: 16.99 to 34.09). The number of conditions used to assess multimorbidity ranged from four to nine. The major risk factors identified were increasing age, urban residence, and lower literacy rates.</p><p><strong>Conclusion: </strong>A wide variance in the prevalence of multimorbidity was observed. Moreover, multimorbidity assessment tool/conditions considered for assessing multimorbidity were heterogeneous.</p>","PeriodicalId":73843,"journal":{"name":"Journal of multimorbidity and comorbidity","volume":"14 ","pages":"26335565241284022"},"PeriodicalIF":0.0,"publicationDate":"2024-09-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11409287/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142302669","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Changes in multimorbidity among hospitalized adults in the US. 美国住院成年人的多病症变化。
Pub Date : 2024-09-03 eCollection Date: 2024-01-01 DOI: 10.1177/26335565241283436
Christine Loyd, Lauren Picken, Richelle Sanders, Yue Zhang, Richard E Kennedy, Cynthia J Brown

Objective: This investigation examines burden of comorbidity measured by the Charlson Comorbidity Index (CCI) and Elixhauser Comorbidity Index (ECI) among inpatients based on age, sex, and race.

Methods: Cross-sectional analysis of 2012-2018 US NIS datasets. Participants were inpatients 55y+. ICD-9/10 codes for admitting diagnoses were used to calculate disease burden using the CCI and ECI. Unweighted mean CCI and ECI scores were compared across demographic variables.

Results: An increase in mean CCI and ECI scores across age, sex, and races (p<.001) was identified. Compared to the youngest age group (55-59y), all age groups had higher mean CCI and ECI adjusting for time (p<.001). Increases were greatest in older age groups until age 80-84 for CCI and 85-89 for ECI. The female group had lower CCI adjusting for time (p<.001) compared to males. There was no difference between sex groups in mean ECI (p=.409). Compared with the White group, all other race groups had higher mean CCI adjusting for time (p<.001). Black inpatients had the highest CCI followed by Native American inpatients. Findings were similar for ECI, but with no difference between Hispanic and White groups (p=.434).

Conclusions: Growing multimorbidity burden among adult inpatients across age, sex, and race supports the continued need for programs for preventing and reducing multimorbidity, especially among communities that experience health inequity including older, Black, and Native American patients.

调查目的本调查根据年龄、性别和种族,对住院患者的合并症负担进行了研究,合并症负担是通过查尔森合并症指数(CCI)和埃利克豪斯合并症指数(ECI)来衡量的:方法:对 2012-2018 年美国 NIS 数据集进行横断面分析。参与者为 55 岁以上的住院患者。入院诊断的 ICD-9/10 代码用于使用 CCI 和 ECI 计算疾病负担。对不同人口统计学变量的非加权平均 CCI 和 ECI 分数进行比较:结果:CCI和ECI的平均得分在不同年龄、性别和种族之间均有所上升(p结论:不同年龄、性别和种族的成人住院病人的多病负担日益加重,这说明仍有必要制定预防和减少多病负担的计划,尤其是在老年人、黑人和美国原住民病人等健康不公平的群体中。
{"title":"Changes in multimorbidity among hospitalized adults in the US.","authors":"Christine Loyd, Lauren Picken, Richelle Sanders, Yue Zhang, Richard E Kennedy, Cynthia J Brown","doi":"10.1177/26335565241283436","DOIUrl":"10.1177/26335565241283436","url":null,"abstract":"<p><strong>Objective: </strong>This investigation examines burden of comorbidity measured by the Charlson Comorbidity Index (CCI) and Elixhauser Comorbidity Index (ECI) among inpatients based on age, sex, and race.</p><p><strong>Methods: </strong>Cross-sectional analysis of 2012-2018 US NIS datasets. Participants were inpatients 55y+. ICD-9/10 codes for admitting diagnoses were used to calculate disease burden using the CCI and ECI. Unweighted mean CCI and ECI scores were compared across demographic variables.</p><p><strong>Results: </strong>An increase in mean CCI and ECI scores across age, sex, and races (p<.001) was identified. Compared to the youngest age group (55-59y), all age groups had higher mean CCI and ECI adjusting for time (p<.001). Increases were greatest in older age groups until age 80-84 for CCI and 85-89 for ECI. The female group had lower CCI adjusting for time (p<.001) compared to males. There was no difference between sex groups in mean ECI (p=.409). Compared with the White group, all other race groups had higher mean CCI adjusting for time (p<.001). Black inpatients had the highest CCI followed by Native American inpatients. Findings were similar for ECI, but with no difference between Hispanic and White groups (p=.434).</p><p><strong>Conclusions: </strong>Growing multimorbidity burden among adult inpatients across age, sex, and race supports the continued need for programs for preventing and reducing multimorbidity, especially among communities that experience health inequity including older, Black, and Native American patients.</p>","PeriodicalId":73843,"journal":{"name":"Journal of multimorbidity and comorbidity","volume":"14 ","pages":"26335565241283436"},"PeriodicalIF":0.0,"publicationDate":"2024-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11375669/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142141942","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Epidemiology and impact of chronic disease multimorbidity in India: a systematic review and meta-analysis. 印度慢性病多发病的流行病学及其影响:系统回顾与荟萃分析。
Pub Date : 2024-06-05 eCollection Date: 2024-01-01 DOI: 10.1177/26335565241258851
Roja Varanasi, Abhinav Sinha, Meenakshi Bhatia, Debadatta Nayak, Raj K Manchanda, Rajeev Janardhanan, John Tayu Lee, Simran Tandon, Sanghamitra Pati

Objectives: This is the first systematic review and meta-analysis of the prevalence of multimorbidity, its risk factors including socioeconomic factors, and the consequences of multimorbidity on health systems and broader society in India.

Methods: A systematic review of both published and grey literature from five databases (Medline, Embase, EBSCO, Scopus, and ProQuest) was conducted including original studies documenting prevalence or patient outcomes associated with multimorbidity among adults in India. We excluded studies that did not explicitly mention multimorbidity. Three independent reviewers did primary screening based on titles and abstracts followed by full-text review for potential eligibility. The risk of bias was independently assessed by two reviewers following the Appraisal Tool for Cross-Sectional Studies. We presented both qualitative and quantitative (through meta-analysis) summaries of the evidence. The protocol for this study was prospectively registered with PROSPERO (CRD42021257281).

Results: The review identified 5442 articles out of which 35 articles were finally included in this study. Twenty-three studies were based on the primary data while 12 used secondary data. Eleven studies were conducted in hospital/primary care setting while 24 were community-based. The pooled prevalence of multimorbidity based on (n=19) studies included for meta-analysis was 20% (95% CI: 19% to 20%). The most frequent outcomes were increased healthcare utilization, reduced health-related quality of life, physical and mental functioning.

Conclusion: We identified a wide variance in the magnitude of multimorbidity across age groups and regions with most of the studies from eastern India. Nation-wide studies, studies on vulnerable populations and interventions are warranted.

目标:这是首次对印度的多病症患病率、其风险因素(包括社会经济因素)以及多病症对医疗系统和更广泛的社会造成的后果进行系统回顾和荟萃分析:我们对五个数据库(Medline、Embase、EBSCO、Scopus 和 ProQuest)中已发表的文献和灰色文献进行了系统综述,其中包括记录印度成人中多病症患病率或患者相关结果的原创研究。我们排除了未明确提及多病症的研究。三位独立审稿人根据标题和摘要进行初筛,然后进行全文审阅,以确定是否符合条件。偏倚风险由两名审稿人根据横断面研究评估工具进行独立评估。我们对证据进行了定性和定量(通过荟萃分析)总结。本研究的方案已在 PROSPERO(CRD42021257281)进行了前瞻性注册:综述共发现了 5442 篇文章,其中 35 篇最终被纳入本研究。23 项研究基于原始数据,12 项研究使用了二手数据。有 11 项研究在医院/初级医疗机构进行,24 项研究在社区进行。根据纳入荟萃分析的 19 项研究,多病共存率为 20%(95% CI:19% 至 20%)。最常见的结果是医疗保健使用增加、与健康相关的生活质量下降、身体和心理功能下降:我们发现不同年龄组和地区的多病症程度差异很大,其中大部分研究来自印度东部。有必要在全国范围内开展研究,并对弱势群体和干预措施进行研究。
{"title":"Epidemiology and impact of chronic disease multimorbidity in India: a systematic review and meta-analysis.","authors":"Roja Varanasi, Abhinav Sinha, Meenakshi Bhatia, Debadatta Nayak, Raj K Manchanda, Rajeev Janardhanan, John Tayu Lee, Simran Tandon, Sanghamitra Pati","doi":"10.1177/26335565241258851","DOIUrl":"10.1177/26335565241258851","url":null,"abstract":"<p><strong>Objectives: </strong>This is the first systematic review and meta-analysis of the prevalence of multimorbidity, its risk factors including socioeconomic factors, and the consequences of multimorbidity on health systems and broader society in India.</p><p><strong>Methods: </strong>A systematic review of both published and grey literature from five databases (Medline, Embase, EBSCO, Scopus, and ProQuest) was conducted including original studies documenting prevalence or patient outcomes associated with multimorbidity among adults in India. We excluded studies that did not explicitly mention multimorbidity. Three independent reviewers did primary screening based on titles and abstracts followed by full-text review for potential eligibility. The risk of bias was independently assessed by two reviewers following the Appraisal Tool for Cross-Sectional Studies. We presented both qualitative and quantitative (through meta-analysis) summaries of the evidence. The protocol for this study was prospectively registered with PROSPERO (CRD42021257281).</p><p><strong>Results: </strong>The review identified 5442 articles out of which 35 articles were finally included in this study. Twenty-three studies were based on the primary data while 12 used secondary data. Eleven studies were conducted in hospital/primary care setting while 24 were community-based. The pooled prevalence of multimorbidity based on (n=19) studies included for meta-analysis was 20% (95% CI: 19% to 20%). The most frequent outcomes were increased healthcare utilization, reduced health-related quality of life, physical and mental functioning.</p><p><strong>Conclusion: </strong>We identified a wide variance in the magnitude of multimorbidity across age groups and regions with most of the studies from eastern India. Nation-wide studies, studies on vulnerable populations and interventions are warranted.</p>","PeriodicalId":73843,"journal":{"name":"Journal of multimorbidity and comorbidity","volume":"14 ","pages":"26335565241258851"},"PeriodicalIF":0.0,"publicationDate":"2024-06-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11155324/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141285493","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Multimorbidity and acute infectious diseases in urban and semi-urban settings in Peru: A mixed-methods study. 秘鲁城市和半城市环境中的多病症和急性传染病:混合方法研究。
Pub Date : 2024-05-23 eCollection Date: 2024-01-01 DOI: 10.1177/26335565241256826
Cecilia Anza-Ramirez, Lizzete Najarro, Antonio Bernabé-Ortiz, Francisco Diez-Canseco, Edward Fottrell, Ibrahim Abubakar, Akram Hernández-Vásquez, Rodrigo M Carrillo-Larco, John R Hurst, Juan Jaime Miranda

Background: The co-occurrence of chronic diseases and acute infectious events exacerbates disability and diminishes quality of life, yet research in Low- and Middle-Income countries is scarce. We aimed to investigate the relationship between infectious events and multimorbidity in resource-constrained settings.

Methods: We conducted a sequential mixed-method study in Lima and Tumbes, Peru, with participants having multimorbidity from the CRONICAS Cohort Study. They completed a questionnaire on the occurrence, treatment, and health-seeking behaviour related to acute infectious events. Qualitative interviews explored the perceptions and links between multimorbidity and acute infectious events for a subgroup of participants.

Findings: Among individuals with multimorbidity, low awareness of chronic conditions and poor medication adherence. The cumulative incidence for respiratory and gastrointestinal infections, the most reported acute conditions, was 2.0 [95%CI: 1.8-2.2] and 1.6 [1.2-1.9] events per person per year, respectively. Individuals with cancer (6.4 [1.6-11.2] events per person per year) or gastrointestinal reflux (7.2 [4.4-10.1] events per person per year) reported higher cumulative incidence of infectious events than others, such as those with cardiovascular and metabolic conditions (5.2 [4.6-5.8] events per person per year). Those with three or more chronic conditions had a slightly higher cumulative incidence compared with individuals with two conditions (5.7 [4.4-7.0] vs 5.0 [4.4-5.6] events per person per year). Around 40% of individuals with multimorbidity sought healthcare assistance, while others chose drugstores or didn't seek help. Our qualitative analysis showed diverse perceptions among participants regarding the connections between chronic and acute conditions. Those who recognized a connection emphasized the challenges in managing these interactions.

Interpretation: Our study advances understanding of multimorbidity challenges in resource-limited settings, highlighting the impact of acute infections on patients' existing multimorbidity burden.

背景:慢性疾病和急性传染病并发会加剧残疾并降低生活质量,但在中低收入国家开展的研究却很少。我们的目的是在资源有限的环境中调查传染病事件与多病症之间的关系:我们在秘鲁利马和通贝斯开展了一项顺序混合方法研究,研究对象是 CRONICAS 队列研究中的多病症患者。他们填写了一份关于急性传染病的发生、治疗和就医行为的调查问卷。定性访谈探讨了一部分参与者对多病症和急性传染病之间的看法和联系:在多病人群中,慢性病意识薄弱,用药依从性差。报告最多的急性疾病是呼吸道感染和胃肠道感染,其累计发病率分别为每人每年 2.0 [95%CI: 1.8-2.2] 次和 1.6 [1.2-1.9] 次。癌症患者(每人每年 6.4 [1.6-11.2] 次)或胃肠道反流患者(每人每年 7.2 [4.4-10.1] 次)的感染事件累计发生率高于心血管和代谢疾病患者(每人每年 5.2 [4.6-5.8] 次)。患有三种或三种以上慢性疾病的患者的累计发病率略高于患有两种疾病的患者(每人每年 5.7 [4.4-7.0] 次 vs 5.0 [4.4-5.6] 次)。约 40% 的多病症患者寻求医疗援助,而其他人则选择药店或不寻求帮助。我们的定性分析显示,参与者对慢性病和急性病之间的联系有不同的看法。那些认识到两者之间存在联系的人强调了在处理这些相互作用时所面临的挑战:我们的研究加深了人们对资源有限环境中多病挑战的理解,强调了急性感染对患者现有多病负担的影响。
{"title":"Multimorbidity and acute infectious diseases in urban and semi-urban settings in Peru: A mixed-methods study.","authors":"Cecilia Anza-Ramirez, Lizzete Najarro, Antonio Bernabé-Ortiz, Francisco Diez-Canseco, Edward Fottrell, Ibrahim Abubakar, Akram Hernández-Vásquez, Rodrigo M Carrillo-Larco, John R Hurst, Juan Jaime Miranda","doi":"10.1177/26335565241256826","DOIUrl":"10.1177/26335565241256826","url":null,"abstract":"<p><strong>Background: </strong>The co-occurrence of chronic diseases and acute infectious events exacerbates disability and diminishes quality of life, yet research in Low- and Middle-Income countries is scarce. We aimed to investigate the relationship between infectious events and multimorbidity in resource-constrained settings.</p><p><strong>Methods: </strong>We conducted a sequential mixed-method study in Lima and Tumbes, Peru, with participants having multimorbidity from the CRONICAS Cohort Study. They completed a questionnaire on the occurrence, treatment, and health-seeking behaviour related to acute infectious events. Qualitative interviews explored the perceptions and links between multimorbidity and acute infectious events for a subgroup of participants.</p><p><strong>Findings: </strong>Among individuals with multimorbidity, low awareness of chronic conditions and poor medication adherence. The cumulative incidence for respiratory and gastrointestinal infections, the most reported acute conditions, was 2.0 [95%CI: 1.8-2.2] and 1.6 [1.2-1.9] events per person per year, respectively. Individuals with cancer (6.4 [1.6-11.2] events per person per year) or gastrointestinal reflux (7.2 [4.4-10.1] events per person per year) reported higher cumulative incidence of infectious events than others, such as those with cardiovascular and metabolic conditions (5.2 [4.6-5.8] events per person per year). Those with three or more chronic conditions had a slightly higher cumulative incidence compared with individuals with two conditions (5.7 [4.4-7.0] vs 5.0 [4.4-5.6] events per person per year). Around 40% of individuals with multimorbidity sought healthcare assistance, while others chose drugstores or didn't seek help. Our qualitative analysis showed diverse perceptions among participants regarding the connections between chronic and acute conditions. Those who recognized a connection emphasized the challenges in managing these interactions.</p><p><strong>Interpretation: </strong>Our study advances understanding of multimorbidity challenges in resource-limited settings, highlighting the impact of acute infections on patients' existing multimorbidity burden.</p>","PeriodicalId":73843,"journal":{"name":"Journal of multimorbidity and comorbidity","volume":"14 ","pages":"26335565241256826"},"PeriodicalIF":0.0,"publicationDate":"2024-05-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11119522/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141155251","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Co-designing municipal multimorbidity rehabilitation leveraging health literacy and social networks: Protocol for the CURIA study. 利用健康知识和社交网络共同设计市政多病康复:CURIA研究协议。
Pub Date : 2024-05-21 eCollection Date: 2024-01-01 DOI: 10.1177/26335565241258353
Tina Junge, Gitte Thybo Pihl, Carsten Kronborg Bak, Søren Thorgaard Skou

Background: Managing multimorbidity poses significant challenges for individuals, their families, and society due to issues with health information comprehension, communication with healthcare providers, and navigating the healthcare system. These challenges emphasise the critical need to prioritize individual and organisational health literacy. Multimorbidity is associated with a lack of social support for health; however, social networks and community dynamics can enhance health literacy. The "Co-designing municipal rehabilitation" (CURIA) project targets enhancing individual and organisational health literacy, and social networks for individuals with multimorbidity, with the overall aim of addressing health inequity through a collaborative local co-design process involving stakeholders.

Methods: The CURIA study employs a mixed-method approach that initially explores the health literacy experiences of individuals with multimorbidity participating in rehabilitation programs in selected Danish municipalities and the practices of professionals overseeing these programs. The subsequent co-design process will comprise individuals with multimorbidity, their relatives, municipalities, general practitioners, civil society, and knowledge institutions working together. This iterative and collaborative process involves tailoring and aligning health literacy needs with responsiveness within the context of local healthcare systems and developing supportive social networks.

Discussion: Given the increasing burden of multimorbidity, there is an urgent need to develop evidence-based practice for multimorbidity rehabilitation practices, developed in collaboration with municipalities and civil society. Emphasising self-care support for individuals, managing complex rehabilitation needs, and involving individuals in intervention prioritisation and customisation are crucial aspects addressed by CURIA to enhance health literacy and align municipal rehabilitation with identified needs.

背景:由于在理解健康信息、与医疗服务提供者沟通以及驾驭医疗系统方面存在问题,多病管理给个人、家庭和社会带来了巨大挑战。这些挑战强调了将个人和组织的健康素养放在首位的迫切需要。多病症与缺乏健康方面的社会支持有关;然而,社会网络和社区动态可以提高健康素养。共同设计市政康复"(CURIA)项目的目标是提高个人和组织的健康素养,并为多病症患者建立社会网络,其总体目标是通过利益相关者参与的合作性地方共同设计过程来解决健康不平等问题:CURIA 研究采用了一种混合方法,首先探究在选定的丹麦城市中参与康复计划的多病症患者的健康素养经验,以及监督这些计划的专业人员的做法。随后的共同设计过程将由多病症患者、其亲属、市政当局、全科医生、民间团体和知识机构共同完成。这一反复协作的过程包括在当地医疗保健系统的背景下,调整健康知识普及需求并使之与响应性保持一致,以及发展支持性社会网络:讨论:鉴于多病负担日益加重,迫切需要与市政当局和民间社会合作,开发以证据为基础的多病康复实践。CURIA 强调为个人提供自我护理支持、管理复杂的康复需求,以及让个人参与干预措施的优先排序和定制,这些都是 CURIA 为提高健康素养和使市政康复与已确定的需求保持一致而解决的关键问题。
{"title":"Co-designing municipal multimorbidity rehabilitation leveraging health literacy and social networks: Protocol for the CURIA study.","authors":"Tina Junge, Gitte Thybo Pihl, Carsten Kronborg Bak, Søren Thorgaard Skou","doi":"10.1177/26335565241258353","DOIUrl":"10.1177/26335565241258353","url":null,"abstract":"<p><strong>Background: </strong>Managing multimorbidity poses significant challenges for individuals, their families, and society due to issues with health information comprehension, communication with healthcare providers, and navigating the healthcare system. These challenges emphasise the critical need to prioritize individual and organisational health literacy. Multimorbidity is associated with a lack of social support for health; however, social networks and community dynamics can enhance health literacy. The \"Co-designing municipal rehabilitation\" (CURIA) project targets enhancing individual and organisational health literacy, and social networks for individuals with multimorbidity, with the overall aim of addressing health inequity through a collaborative local co-design process involving stakeholders.</p><p><strong>Methods: </strong>The CURIA study employs a mixed-method approach that initially explores the health literacy experiences of individuals with multimorbidity participating in rehabilitation programs in selected Danish municipalities and the practices of professionals overseeing these programs. The subsequent co-design process will comprise individuals with multimorbidity, their relatives, municipalities, general practitioners, civil society, and knowledge institutions working together. This iterative and collaborative process involves tailoring and aligning health literacy needs with responsiveness within the context of local healthcare systems and developing supportive social networks.</p><p><strong>Discussion: </strong>Given the increasing burden of multimorbidity, there is an urgent need to develop evidence-based practice for multimorbidity rehabilitation practices, developed in collaboration with municipalities and civil society. Emphasising self-care support for individuals, managing complex rehabilitation needs, and involving individuals in intervention prioritisation and customisation are crucial aspects addressed by CURIA to enhance health literacy and align municipal rehabilitation with identified needs.</p>","PeriodicalId":73843,"journal":{"name":"Journal of multimorbidity and comorbidity","volume":"14 ","pages":"26335565241258353"},"PeriodicalIF":0.0,"publicationDate":"2024-05-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11110505/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141082855","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Conceptualizing COVID-19 syndemics: A scoping review. COVID-19综合征的概念化:范围审查。
Pub Date : 2024-04-26 eCollection Date: 2024-01-01 DOI: 10.1177/26335565241249835
Nicola Bulled, Merrill Singer

Background: COVID-19's heavy toll on human health, and its concentration within specific at-risk groups including the socially vulnerable and individuals with comorbidities, has made it the focus of much syndemic discourse. Syndemic theory recognizes that social factors create the conditions that support the clustering of diseases and that these diseases interact in a manner that worsens health outcomes. Syndemics theory has helped to facilitate systems-level approaches to disease as a biosocial phenomenon and guide prevention and treatment efforts. Despite its recognized value, reviews of syndemics literature have noted frequent misuse of the concept limiting its potential in guiding appropriate interventions.

Objective: To review how the term 'syndemic' is defined and applied within peer-reviewed literature in relation to COVID-19.

Design: A scoping review of definitions within COVID-19 literature published between January 1, 2020 to May 15, 2023 was conducted. Searches took place across six databases: Academic Search Premier, CINAHL, JSTOR, MEDLINE/Pubmed, PsycINFO and Scopus. PRISMA-ScR guidelines were followed.

Results: Content analysis revealed that COVID-19 has varied clustered configurations of communicable-non-communicable diseases and novel communicable disease interactions. Spatial analysis was presented as a new strategy to evidence syndemic arrangements. However, syndemics continue to be regarded as universal, with continued misunderstanding and misapplication of the concept.

Conclusion: This review found that current applications of syndemics remain problematic. Recommendations are made on the design of syndemic studies. A syndemic framework offers an opportunity for systems-level thinking that considers the full complexity of human-disease interactions and is useful to inform future pandemic preparations and responses.

背景:COVID-19 对人类健康的严重危害,以及它对特定高危人群(包括社会弱势群体和合并症患者)的集中影响,使其成为许多综合症讨论的焦点。综合症理论认为,社会因素创造了支持疾病聚集的条件,这些疾病相互作用,导致健康状况恶化。综合症理论有助于从系统层面将疾病视为一种生物社会现象,并指导预防和治疗工作。尽管辛迪加学说的价值已得到公认,但有关辛迪加学说文献的评论指出,这一概念经常被滥用,从而限制了其在指导适当干预措施方面的潜力:回顾同行评议文献中如何定义和应用与 COVID-19 相关的 "综合征 "一词:设计:对 2020 年 1 月 1 日至 2023 年 5 月 15 日期间发表的 COVID-19 文献中的定义进行范围界定。在六个数据库中进行了检索:Academic Search Premier、CINAHL、JSTOR、MEDLINE/Pubmed、PsycINFO 和 Scopus。结果:内容分析表明,COVID-19 具有不同的传染病-非传染病聚类配置和新型传染病相互作用。空间分析作为一种新的策略被提出来,以证明群体性安排。然而,综合征仍被视为普遍现象,对这一概念的误解和误用仍在继续:本综述发现,目前对综合症的应用仍然存在问题。本文就综合症研究的设计提出了建议。综合症框架为系统层面的思考提供了机会,这种思考考虑了人类与疾病相互作用的全部复杂性,有助于为未来大流行病的准备和应对提供信息。
{"title":"Conceptualizing COVID-19 syndemics: A scoping review.","authors":"Nicola Bulled, Merrill Singer","doi":"10.1177/26335565241249835","DOIUrl":"10.1177/26335565241249835","url":null,"abstract":"<p><strong>Background: </strong>COVID-19's heavy toll on human health, and its concentration within specific at-risk groups including the socially vulnerable and individuals with comorbidities, has made it the focus of much syndemic discourse. Syndemic theory recognizes that social factors create the conditions that support the clustering of diseases and that these diseases interact in a manner that worsens health outcomes. Syndemics theory has helped to facilitate systems-level approaches to disease as a biosocial phenomenon and guide prevention and treatment efforts. Despite its recognized value, reviews of syndemics literature have noted frequent misuse of the concept limiting its potential in guiding appropriate interventions.</p><p><strong>Objective: </strong>To review how the term 'syndemic' is defined and applied within peer-reviewed literature in relation to COVID-19.</p><p><strong>Design: </strong>A scoping review of definitions within COVID-19 literature published between January 1, 2020 to May 15, 2023 was conducted. Searches took place across six databases: Academic Search Premier, CINAHL, JSTOR, MEDLINE/Pubmed, PsycINFO and Scopus. PRISMA-ScR guidelines were followed.</p><p><strong>Results: </strong>Content analysis revealed that COVID-19 has varied clustered configurations of communicable-non-communicable diseases and novel communicable disease interactions. Spatial analysis was presented as a new strategy to evidence syndemic arrangements. However, syndemics continue to be regarded as universal, with continued misunderstanding and misapplication of the concept.</p><p><strong>Conclusion: </strong>This review found that current applications of syndemics remain problematic. Recommendations are made on the design of syndemic studies. A syndemic framework offers an opportunity for systems-level thinking that considers the full complexity of human-disease interactions and is useful to inform future pandemic preparations and responses.</p>","PeriodicalId":73843,"journal":{"name":"Journal of multimorbidity and comorbidity","volume":"14 ","pages":"26335565241249835"},"PeriodicalIF":0.0,"publicationDate":"2024-04-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11055430/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140874151","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assigning disease clusters to people: A cohort study of the implications for understanding health outcomes in people with multiple long-term conditions. 为人群分配疾病群:一项队列研究,旨在了解多种长期疾病患者的健康结果。
Pub Date : 2024-04-17 eCollection Date: 2024-01-01 DOI: 10.1177/26335565241247430
Thomas Beaney, Jonathan Clarke, David Salman, Thomas Woodcock, Azeem Majeed, Mauricio Barahona, Paul Aylin

Background: Identifying clusters of co-occurring diseases may help characterise distinct phenotypes of Multiple Long-Term Conditions (MLTC). Understanding the associations of disease clusters with health-related outcomes requires a strategy to assign clusters to people, but it is unclear how the performance of strategies compare.

Aims: First, to compare the performance of methods of assigning disease clusters to people at explaining mortality, emergency department attendances and hospital admissions over one year. Second, to identify the extent of variation in the associations with each outcome between and within clusters.

Methods: We conducted a cohort study of primary care electronic health records in England, including adults with MLTC. Seven strategies were tested to assign patients to fifteen disease clusters representing 212 LTCs, identified from our previous work. We tested the performance of each strategy at explaining associations with the three outcomes over 1 year using logistic regression and compared to a strategy using the individual LTCs.

Results: 6,286,233 patients with MLTC were included. Of the seven strategies tested, a strategy assigning the count of conditions within each cluster performed best at explaining all three outcomes but was inferior to using information on the individual LTCs. There was a larger range of effect sizes for the individual LTCs within the same cluster than there was between the clusters.

Conclusion: Strategies of assigning clusters of co-occurring diseases to people were less effective at explaining health-related outcomes than a person's individual diseases. Furthermore, clusters did not represent consistent relationships of the LTCs within them, which might limit their application in clinical research.

背景:识别并发疾病群可能有助于描述多重长期病症(MLTC)的不同表型。要了解疾病群与健康相关结果之间的关联,就需要制定一种将疾病群分配给患者的策略,但目前还不清楚各种策略的效果比较。目的:首先,比较将疾病群分配给患者的方法在解释一年内死亡率、急诊就诊率和入院率方面的效果。其次,确定群组之间和群组内部与每种结果的关联差异程度:我们对英格兰的初级保健电子健康记录进行了一项队列研究,其中包括患有多发性硬化症的成年人。我们对七种策略进行了测试,以将患者分配到代表 212 种 LTC 的 15 个疾病群组中,这些疾病群组是在我们之前的工作中确定的。我们使用逻辑回归法测试了每种策略在解释一年内三种结果的关联性方面的表现,并与使用单个 LTCs 的策略进行了比较:共纳入 6,286,233 名多发性硬化症患者。在测试的七种策略中,在解释所有三种结果时,分配每个群组中的病症计数的策略表现最佳,但不如使用单个 LTCs 信息的策略。同一群组内单个 LTC 的效应大小范围大于群组之间的效应大小范围:结论:在解释与健康相关的结果时,将并发疾病群组分配给个人的策略不如个人的单个疾病有效。此外,聚类并不代表其内部长期治疗疾病之间的一致关系,这可能会限制其在临床研究中的应用。
{"title":"Assigning disease clusters to people: A cohort study of the implications for understanding health outcomes in people with multiple long-term conditions.","authors":"Thomas Beaney, Jonathan Clarke, David Salman, Thomas Woodcock, Azeem Majeed, Mauricio Barahona, Paul Aylin","doi":"10.1177/26335565241247430","DOIUrl":"10.1177/26335565241247430","url":null,"abstract":"<p><strong>Background: </strong>Identifying clusters of co-occurring diseases may help characterise distinct phenotypes of Multiple Long-Term Conditions (MLTC). Understanding the associations of disease clusters with health-related outcomes requires a strategy to assign clusters to people, but it is unclear how the performance of strategies compare.</p><p><strong>Aims: </strong>First, to compare the performance of methods of assigning disease clusters to people at explaining mortality, emergency department attendances and hospital admissions over one year. Second, to identify the extent of variation in the associations with each outcome between and within clusters.</p><p><strong>Methods: </strong>We conducted a cohort study of primary care electronic health records in England, including adults with MLTC. Seven strategies were tested to assign patients to fifteen disease clusters representing 212 LTCs, identified from our previous work. We tested the performance of each strategy at explaining associations with the three outcomes over 1 year using logistic regression and compared to a strategy using the individual LTCs.</p><p><strong>Results: </strong>6,286,233 patients with MLTC were included. Of the seven strategies tested, a strategy assigning the count of conditions within each cluster performed best at explaining all three outcomes but was inferior to using information on the individual LTCs. There was a larger range of effect sizes for the individual LTCs within the same cluster than there was between the clusters.</p><p><strong>Conclusion: </strong>Strategies of assigning clusters of co-occurring diseases to people were less effective at explaining health-related outcomes than a person's individual diseases. Furthermore, clusters did not represent consistent relationships of the LTCs within them, which might limit their application in clinical research.</p>","PeriodicalId":73843,"journal":{"name":"Journal of multimorbidity and comorbidity","volume":"14 ","pages":"26335565241247430"},"PeriodicalIF":0.0,"publicationDate":"2024-04-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11025432/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140873798","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Multimorbidity trajectories in early adulthood and middle age: Findings from the CARDIA prospective cohort study. 成年早期和中年期的多病症轨迹:CARDIA前瞻性队列研究的结果。
Pub Date : 2024-04-05 eCollection Date: 2024-01-01 DOI: 10.1177/26335565241242277
C Barrett Bowling, Richard A Faldowski, Richard Sloane, Carl Pieper, Tyson H Brown, Erin E Dooley, Brett T Burrows, Norrina B Allen, Kelley Pettee Gabriel, Cora E Lewis

Background: Multimorbidity research has focused on the prevalence and consequences of multimorbidity in older populations. Less is known about the accumulation of chronic conditions earlier in the life course.

Methods: We identified patterns of longitudinal multimorbidity accumulation using 30 years of data from in-person exams, annual follow-ups, and adjudicated end-points among 4,945 participants of the Coronary Artery Risk Development in Young Adults (CARDIA) study. Chronic conditions included arthritis, asthma, atrial fibrillation, cancer, end stage renal disease, chronic obstructive pulmonary disease, coronary heart disease, diabetes, heart failure, hyperlipidemia, hypertension, and stroke. Trajectory patterns were identified using latent class growth curve models.

Results: Mean age (SD) at baseline (1985-6) was 24.9 (3.6), 55% were female, and 51% were Black. The median follow-up was 30 years (interquartile range 25-30). We identified six trajectory classes characterized by when conditions began to accumulate and the rapidity of accumulation: (1) early-fifties, slow, (2) mid-forties, fast, (3) mid-thirties, fast, (4) late-twenties, slow, (5) mid-twenties, slow, and (6) mid-twenties, fast. Compared with participants in the early-fifties, slow trajectory class, participants in mid-twenties, fast were more likely to be female, Black, and currently smoking and had a higher baseline mean waist circumference (83.6 vs. 75.6 cm) and BMI (27.0 vs. 23.4 kg/m2) and lower baseline physical activity (414.1 vs. 442.4 exercise units).

Conclusions: A life course approach that recognizes the heterogeneity in patterns of accumulation of chronic conditions from early adulthood into middle age could be helpful for identifying high risk subgroups and developing approaches to delay multimorbidity progression.

背景:多病研究主要集中在老年人群中多病的发病率和后果。但对于慢性病在生命早期的积累情况却知之甚少:我们利用 30 年来的亲自检查、年度随访和裁定终点的数据,在 4,945 名参加冠状动脉风险发展(CARDIA)研究的年轻人中确定了多病症纵向累积的模式。慢性疾病包括关节炎、哮喘、心房颤动、癌症、终末期肾病、慢性阻塞性肺病、冠心病、糖尿病、心力衰竭、高脂血症、高血压和中风。使用潜类增长曲线模型确定了轨迹模式:基线(1985-6 年)时的平均年龄(标清)为 24.9 岁(3.6),55% 为女性,51% 为黑人。随访时间中位数为 30 年(四分位数间距为 25-30 年)。我们根据病情开始累积的时间和累积的速度确定了六个轨迹等级:(1)50 岁出头,速度慢;(2)40 岁中期,速度快;(3)30 岁中期,速度快;(4)20 岁后期,速度慢;(5)20 岁中期,速度慢;(6)20 岁中期,速度快。与 50 岁出头的 "慢速轨迹 "参与者相比,20 多岁的 "快速轨迹 "参与者更有可能是女性、黑人和正在吸烟的人,其基线平均腰围(83.6 厘米对 75.6 厘米)和体重指数(27.0 千克/平方米对 23.4 千克/平方米)较高,基线体力活动量(414.1 对 442.4 运动单位)较低:认识到从成年早期到中年的慢性病累积模式的异质性的生命过程方法有助于识别高风险亚群,并制定方法来延缓多病症的发展。
{"title":"Multimorbidity trajectories in early adulthood and middle age: Findings from the CARDIA prospective cohort study.","authors":"C Barrett Bowling, Richard A Faldowski, Richard Sloane, Carl Pieper, Tyson H Brown, Erin E Dooley, Brett T Burrows, Norrina B Allen, Kelley Pettee Gabriel, Cora E Lewis","doi":"10.1177/26335565241242277","DOIUrl":"10.1177/26335565241242277","url":null,"abstract":"<p><strong>Background: </strong>Multimorbidity research has focused on the prevalence and consequences of multimorbidity in older populations. Less is known about the accumulation of chronic conditions earlier in the life course.</p><p><strong>Methods: </strong>We identified patterns of longitudinal multimorbidity accumulation using 30 years of data from in-person exams, annual follow-ups, and adjudicated end-points among 4,945 participants of the Coronary Artery Risk Development in Young Adults (CARDIA) study. Chronic conditions included arthritis, asthma, atrial fibrillation, cancer, end stage renal disease, chronic obstructive pulmonary disease, coronary heart disease, diabetes, heart failure, hyperlipidemia, hypertension, and stroke. Trajectory patterns were identified using latent class growth curve models.</p><p><strong>Results: </strong>Mean age (SD) at baseline (1985-6) was 24.9 (3.6), 55% were female, and 51% were Black. The median follow-up was 30 years (interquartile range 25-30). We identified six trajectory classes characterized by when conditions began to accumulate and the rapidity of accumulation: (1) early-fifties, slow, (2) mid-forties, fast, (3) mid-thirties, fast, (4) late-twenties, slow, (5) mid-twenties, slow, and (6) mid-twenties, fast. Compared with participants in the early-fifties, slow trajectory class, participants in mid-twenties, fast were more likely to be female, Black, and currently smoking and had a higher baseline mean waist circumference (83.6 vs. 75.6 cm) and BMI (27.0 vs. 23.4 kg/m<sup>2</sup>) and lower baseline physical activity (414.1 vs. 442.4 exercise units).</p><p><strong>Conclusions: </strong>A life course approach that recognizes the heterogeneity in patterns of accumulation of chronic conditions from early adulthood into middle age could be helpful for identifying high risk subgroups and developing approaches to delay multimorbidity progression.</p>","PeriodicalId":73843,"journal":{"name":"Journal of multimorbidity and comorbidity","volume":"14 ","pages":"26335565241242277"},"PeriodicalIF":0.0,"publicationDate":"2024-04-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10998492/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140874321","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of multimorbidity and comorbidity
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1